Free Trial

Envista Holdings Corporation (NYSE:NVST) Short Interest Up 32.8% in March

Envista logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Short interest surged 32.8% to 9,691,732 shares as of March 31, implying a short-interest ratio of 4.1 days and that about 6.0% of the company's stock is currently shorted.
  • Analysts hold a consensus rating of "Hold" on Envista with a consensus price target of $27.69 after a mix of recent upgrades and downgrades.
  • Envista beat quarterly EPS estimates (reported $0.38 vs. $0.32 expected) with revenue up 15% year-over-year and set FY2026 guidance of 1.350–1.450 EPS.
  • Five stocks to consider instead of Envista.

Envista Holdings Corporation (NYSE:NVST - Get Free Report) saw a significant growth in short interest during the month of March. As of March 31st, there was short interest totaling 9,691,732 shares, a growth of 32.8% from the March 15th total of 7,296,729 shares. Based on an average daily volume of 2,379,616 shares, the short-interest ratio is presently 4.1 days. Currently, 6.0% of the company's stock are short sold.

Wall Street Analyst Weigh In

NVST has been the topic of a number of recent research reports. Weiss Ratings upgraded shares of Envista from a "sell (d)" rating to a "hold (c-)" rating in a report on Tuesday, February 17th. Stifel Nicolaus set a $31.00 price objective on shares of Envista in a report on Friday, February 6th. Zacks Research downgraded shares of Envista from a "strong-buy" rating to a "hold" rating in a report on Monday, April 6th. JPMorgan Chase & Co. lifted their price objective on shares of Envista from $22.00 to $26.00 and gave the company a "neutral" rating in a report on Friday, February 6th. Finally, Robert W. Baird set a $30.00 price objective on shares of Envista in a report on Friday, February 6th. Seven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $27.69.

Check Out Our Latest Stock Report on Envista

Insider Activity

In other news, SVP Mischa Reis sold 9,675 shares of Envista stock in a transaction that occurred on Tuesday, February 10th. The shares were sold at an average price of $30.00, for a total value of $290,250.00. Following the sale, the senior vice president directly owned 32,382 shares in the company, valued at $971,460. This trade represents a 23.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.66% of the stock is owned by company insiders.

Hedge Funds Weigh In On Envista

Institutional investors have recently added to or reduced their stakes in the company. Dimensional Fund Advisors LP increased its holdings in shares of Envista by 0.9% in the fourth quarter. Dimensional Fund Advisors LP now owns 9,628,460 shares of the company's stock valued at $209,036,000 after purchasing an additional 90,586 shares during the last quarter. Alliancebernstein L.P. increased its holdings in shares of Envista by 34.0% in the second quarter. Alliancebernstein L.P. now owns 6,098,445 shares of the company's stock valued at $119,164,000 after purchasing an additional 1,547,656 shares during the last quarter. Massachusetts Financial Services Co. MA increased its holdings in shares of Envista by 15.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 3,349,874 shares of the company's stock valued at $72,726,000 after purchasing an additional 444,725 shares during the last quarter. Millennium Management LLC increased its holdings in shares of Envista by 1,442.7% in the fourth quarter. Millennium Management LLC now owns 2,420,615 shares of the company's stock valued at $52,552,000 after purchasing an additional 2,263,712 shares during the last quarter. Finally, AQR Capital Management LLC increased its holdings in shares of Envista by 72.3% in the fourth quarter. AQR Capital Management LLC now owns 2,356,968 shares of the company's stock valued at $51,170,000 after purchasing an additional 988,714 shares during the last quarter.

Envista Stock Up 3.2%

NVST traded up $0.87 during trading on Friday, reaching $27.81. 1,804,013 shares of the stock were exchanged, compared to its average volume of 2,753,227. The stock has a market cap of $4.53 billion, a P/E ratio of 99.32, a price-to-earnings-growth ratio of 1.85 and a beta of 0.98. Envista has a twelve month low of $14.72 and a twelve month high of $30.42. The stock's 50 day moving average price is $27.16 and its two-hundred day moving average price is $23.41. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.38.

Envista (NYSE:NVST - Get Free Report) last issued its earnings results on Thursday, February 5th. The company reported $0.38 earnings per share for the quarter, topping analysts' consensus estimates of $0.32 by $0.06. Envista had a net margin of 1.73% and a return on equity of 6.54%. The business's quarterly revenue was up 15.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. Equities analysts expect that Envista will post 1 EPS for the current year.

About Envista

(Get Free Report)

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company's offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista's product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Envista Right Now?

Before you consider Envista, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Envista wasn't on the list.

While Envista currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before SpaceX Goes Public Cover

A forward-looking investment report spotlighting the seven space companies best positioned to benefit from accelerating commercialization in 2026. It explores key industry trends, major growth catalysts, and the stocks shaping the next phase of the space economy—from launch leaders and satellite networks to data, defense, and in-space infrastructure.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines